Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

NCT03069144 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis
Psoriasis Vulgaris

Interventions

DRUG: HAT1 topical solution
DRUG: Calcipotriol

Sponsor

Haus Bioceuticals